{
    "pmid": "41474169",
    "title": "Molecular Characterization of Carbapenemases in Gram-negative Bacilli Infections: A 5-Year, Retrospective, Observational Study at a Tertiary Care Center.",
    "abstract": "Carbapenem-resistant Gram-negative bacilli (CR-GNB) pose a major public health threat due to limited treatment options and high mortality. Rapid molecular assays can facilitate the timely detection and improve clinical outcomes. To characterize carbapenemase genes in Gram-negative bacilli using the Xpert Carba-R assay over 5 years and to assess associated infection sites and patient-related risk factors. A retrospective observational study was conducted at a tertiary care center in southern India between October 2019 and December 2024. Clinically significant, nonrepetitive isolates were analyzed using the Xpert Carba-R assay. Demographic and clinical data, infection sites, risk factors, and antibiotic changes following molecular results were recorded. Data were analyzed using Jamovi software. Qualitative variables were expressed as frequencies and percentages; quantitative variables as means and standard deviations. The Chi-square test was applied, and a P â‰¤ 0.05 was considered statistically significant. Of 136 isolates, 129 (94.85%) harbored carbapenemase genes. New Delhi metallo-b-lactamase (NDM) (36.76%) and NDM + oxacillin-hydrolyzing b-lactamase-48 (OXA-48) (31.61%) were most prevalent, while OXA-48 alone declined over time. Klebsiella pneumoniae was predominant, followed by Escherichia coli. Urinary tract infections were most frequent (33.32%), with a significant association between NDM + OXA-48 and UTIs (P = 0.035). Therapy was modified in 48.27% of patients, most often to regimens including ceftazidime-avibactam, aztreonam, or polymyxin B. A shift toward NDM and NDM + OXA-48 genotypes was observed over 5 years. Rapid molecular diagnostics support timely optimization of therapy and antimicrobial stewardship in managing high-risk CR-GNB infections.",
    "disease": "pneumonia",
    "clean_text": "molecular characterization of carbapenemases in gram negative bacilli infections a year retrospective observational study at a tertiary care center carbapenem resistant gram negative bacilli cr gnb pose a major public health threat due to limited treatment options and high mortality rapid molecular assays can facilitate the timely detection and improve clinical outcomes to characterize carbapenemase genes in gram negative bacilli using the xpert carba r assay over years and to assess associated infection sites and patient related risk factors a retrospective observational study was conducted at a tertiary care center in southern india between october and december clinically significant nonrepetitive isolates were analyzed using the xpert carba r assay demographic and clinical data infection sites risk factors and antibiotic changes following molecular results were recorded data were analyzed using jamovi software qualitative variables were expressed as frequencies and percentages quantitative variables as means and standard deviations the chi square test was applied and a p was considered statistically significant of isolates harbored carbapenemase genes new delhi metallo b lactamase ndm and ndm oxacillin hydrolyzing b lactamase oxa were most prevalent while oxa alone declined over time klebsiella pneumoniae was predominant followed by escherichia coli urinary tract infections were most frequent with a significant association between ndm oxa and utis p therapy was modified in of patients most often to regimens including ceftazidime avibactam aztreonam or polymyxin b a shift toward ndm and ndm oxa genotypes was observed over years rapid molecular diagnostics support timely optimization of therapy and antimicrobial stewardship in managing high risk cr gnb infections"
}